PNEUMOCOCCAL IMMUNIZATION
Clinical trials for PNEUMOCOCCAL IMMUNIZATION explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL IMMUNIZATION trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL IMMUNIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Korean study to monitor prevenar 20 vaccine safety
⭐️ VACCINE ⭐️ Recruiting nowThis study is checking the safety of the Prevenar 20 vaccine after it is already available in Korea. About 660 people aged 6 weeks and older who are prescribed the vaccine will take part. Researchers will track any side effects for 28 days after the shot.
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 20, 2026 11:55 UTC
-
New vaccine aims to shield infants from pneumonia
Prevention Recruiting nowThis study tests a new vaccine (PCV21) designed to protect babies against 21 types of pneumococcal bacteria, which can cause serious illnesses like pneumonia and meningitis. About 2,195 healthy infants will receive four doses of either the new vaccine or an existing one, starting…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi • Aim: Prevention
Last updated May 22, 2026 14:05 UTC